A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial
一项COVID-VIT-Da随机多中心国际临床试验表明，入院时单次口服100,000 IU胆钙化醇并不能改善COVID-19患者的预后。
期刊:BMC Medicine
影响因子:8.3
doi:10.1186/s12916-022-02290-8
Cannata-Andía, Jorge B; Díaz-Sottolano, Augusto; Fernández, Pehuén; Palomo-Antequera, Carmen; Herrero-Puente, Pablo; Mouzo, Ricardo; Carrillo-López, Natalia; Panizo, Sara; Ibañez, Guillermo H; Cusumano, Carlos A; Ballarino, Carolina; Sánchez-Polo, Vicente; Pefaur-Penna, Jacqueline; Maderuelo-Riesco, Irene; Calviño-Varela, Jesús; Gómez, Mónica D; Gómez-Alonso, Carlos; Cunningham, John; Naves-Díaz, Manuel; Douthat, Walter; Fernández-Martín, José L
